These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer]. Scheufele F; Friess H Chirurg; 2020 May; 91(5):391-395. PubMed ID: 31965198 [TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It? Vivarelli M; Mocchegiani F; Nicolini D; Vecchi A; Conte G; Dalla Bona E; Rossi R; Benedetti Cacciaguerra A Front Oncol; 2022; 12():914203. PubMed ID: 35712487 [TBL] [Abstract][Full Text] [Related]
25. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers. Jeon SK; Lee JM; Lee ES; Yu MH; Joo I; Yoon JH; Jang JY; Lee KB; Lee SH Eur Radiol; 2022 Jan; 32(1):56-66. PubMed ID: 34170366 [TBL] [Abstract][Full Text] [Related]
26. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. van Dam MA; Vuijk FA; Stibbe JA; Houvast RD; Luelmo SAC; Crobach S; Shahbazi Feshtali S; de Geus-Oei LF; Bonsing BA; Sier CFM; Kuppen PJK; Swijnenburg RJ; Windhorst AD; Burggraaf J; Vahrmeijer AL; Mieog JSD Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885196 [TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapeutic options for pancreatic ductal adenocarcinoma. Sardar M; Recio-Boiles A; Mody K; Karime C; Chandana SR; Mahadevan D; Starr J; Jones J; Borad M; Babiker H Expert Opin Pharmacother; 2022 Dec; 23(18):2079-2089. PubMed ID: 36394449 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going. Coppola A; Farolfi T; La Vaccara V; Iannone I; Giovinazzo F; Panettieri E; Tarallo M; Cammarata R; Coppola R; Caputo D J Clin Med; 2023 May; 12(11):. PubMed ID: 37297872 [TBL] [Abstract][Full Text] [Related]
29. Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives. de Scordilli M; Michelotti A; Zara D; Palmero L; Alberti M; Noto C; Totaro F; Foltran L; Guardascione M; Iacono D; Ongaro E; Fasola G; Puglisi F Crit Rev Oncol Hematol; 2023 Jun; 186():104013. PubMed ID: 37116817 [TBL] [Abstract][Full Text] [Related]
31. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study. Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715 [TBL] [Abstract][Full Text] [Related]
35. Current Surgical Concepts and Future Perspectives in the Treatment of Borderline Resectable and Potentially Resectable Locally Advanced Pancreatic Cancer. Karamarković AR; Juloski JT Chirurgia (Bucur); 2022 Jun; 117(4):385-398. PubMed ID: 36049095 [TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Glynne-Jones R; Grainger J; Harrison M; Ostler P; Makris A Br J Cancer; 2006 Feb; 94(3):363-71. PubMed ID: 16465172 [TBL] [Abstract][Full Text] [Related]
38. Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis. Yoo C; Shin SH; Kim KP; Jeong JH; Chang HM; Kang JH; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Park JH; Hwang DW; Song KB; Lee JH; Ryoo BY; Kim SC Cancers (Basel); 2019 Feb; 11(3):. PubMed ID: 30813624 [TBL] [Abstract][Full Text] [Related]
39. Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study). Schwarz L; Vernerey D; Bachet JB; Tuech JJ; Portales F; Michel P; Cunha AS BMC Cancer; 2018 Jul; 18(1):762. PubMed ID: 30041614 [TBL] [Abstract][Full Text] [Related]
40. Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies. Pecorelli N; Licinio AW; Guarneri G; Aleotti F; Crippa S; Reni M; Falconi M; Balzano G Front Oncol; 2021; 11():812102. PubMed ID: 35083158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]